TRADING UPDATES: Zenith Energy picks up two solar projects in Italy
27th Apr 2026 20:42
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 9.00p on 28-04-2026 at 10:50:10 |
|---|---|
| Change | 0.15p 1.69% |
| Buy | 9.20p |
| Sell | 8.80p |
| Last Trade: | Buy 25,000.00 at 9.032p |
| Day's Volume: | 1,387,244 |
| Last Close: | 8.85p |
| Open: | 8.85p |
| ISIN: | GB00BYV81293 |
| Day's Range | 8.85p - 9.00p |
| 52wk Range: | 2.25p - 12.35p |
| Market Capitalisation: | £96.16m |
| VWAP: | 8.863044p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 25,000 | 9.032p | Ordinary |
11:42:15 - 28-Apr-26 |
| Sell* | 200,000 | 8.8207p | Ordinary |
11:36:10 - 28-Apr-26 |
| Buy* | 50,000 | 9.04p | Ordinary |
11:22:53 - 28-Apr-26 |
| Buy* | 100,000 | 9.04p | Ordinary |
10:51:00 - 28-Apr-26 |
| Buy* | 60,000 | 9.00p | Ordinary |
10:45:57 - 28-Apr-26 |
| Buy* | 5,000 | 9.00p | Ordinary |
10:32:47 - 28-Apr-26 |
| Buy* | 9,300 | 9.00p | Ordinary |
10:15:07 - 28-Apr-26 |
| Buy* | 2,176 | 9.1875p | Ordinary |
10:04:41 - 28-Apr-26 |
| Unknown* | 500,000 | 8.75p | Ordinary |
10:00:40 - 28-Apr-26 |
| Buy* | 88,987 | 8.99p | Ordinary |
09:43:25 - 28-Apr-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Apr 2026 7:00 am | RNS | Enrollment in Phase II Clinical Trial for ACCRUFeR |
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
| 9th Feb 2026 7:00 am | RNS | FDA Grants additional Exclusivity for ACCRUFeR |
| 30th Jan 2026 7:05 am | RNS | Total Voting Rights |
| 30th Jan 2026 7:00 am | RNS | Approval for ACCRUFeR in China expected in Q1 2026 |